Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027

1.1 Gene Therapy in Oncology Market Snapshot

• Fig.1 Market Snapshot
• Fig.2 Key Segment Performance Snapshot

3.1 What is Gene Therapy?

• Fig.3 History of Gene Therapy Development in Cancer in the 8MM

4.1 Gene Therapy in Oncology Industry Value Chain

• Fig.4 Industry value chain analysis

4.2 Gene Therapy in Oncology Market Structure - PORTER’s Analysis

• Fig.5 Global Gene Therapy in Oncology PORTER’s Five Force Analysis

5.1 Global Gene Therapy in Oncology Market

• Fig.6 Global Gene Therapy in Oncology Market - Revenue Forecast, 2020-2027 (US$ Million)

5.2 COVID-19 Impact

6.1 US
6.2 Europe
6.3 Japan

7.1 Gene Therapy in Oncology - Therapy Type Deep Dive

• Fig.7 Gene Therapy in Oncology by Products- Market Overview
• Fig.8 Gene Therapy in Oncology by Products Share - 2021 & 2027 (%)

7.1.1 ONCOLYTIC VIROTHERAPY

• Fig.9 Oncolytic Virotherapy Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

7.1.2 GENE TRANSFER

• Fig.10 Gene Transfer Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

7.1.3 GENE INDUCED IMMUNOTHERAPY

• Fig.11 Gene Induced Immunotherapy Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

8.1 Gene Therapy in Oncology - End-User Deep Dive

• Fig.12 Gene Therapy in Oncology by Platform- Market Overview
• Fig.13 Gene Therapy in Oncology by End-user - 2021 & 2027 (%)

8.1.1 HOSPITALS

• Fig.14 Hospitals Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

8.1.2 DIAGNOSTIC CENTERS

• Fig.15 Diagnostic Centers Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

8.1.3 RESEARCH INSTITUTES

• Fig.16 Research Institutes Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

9.1 Gene Therapy in Oncology - Regional Deep Dive

• Fig.17 Gene Therapy in Oncology by Region- Market Overview
• Fig.18 Gene Therapy in Oncology by Region Share - 2021 & 2027 (%)

9.1.1 NORTH AMERICA

• Fig.19 North America Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

9.1.2 EUROPE

• Fig.20 Europe Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

9.1.3 ASIA-PACIFIC

• Fig.21 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

9.1.4 REST OF THE WORLD

• Fig.22 ROW Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)

10.1 Gene Therapy in Oncology - Market Trends
10.1.1 THE VIRAL VECTOR GENE THERAPY FIELD IS EXPANDING, BUT HIGH COST IS AN ISSUE
10.1.2 THE NON-VIRAL VECTOR FIELD IS HINDERED BY INEFFICIENT DELIVERY OF TRANSGENES
10.1.3 THERAPEUTIC OLIGONUCLEOTIDES HAVE MAJOR POTENTIAL BUT ARE HINDERED BY INEFFICIENT DELIVERY TO TARGET TISSUE
10.1.4 THE GENOME EDITING FIELD IS IN THE EARLY STAGES OF ITS DEVELOPMENT
10.1.5 THE ONCOLYTIC VIRUS FIELD IS HAMPERED BY LIMITATIONS OF INTRA TUMOR ADMINISTRATION, BUT NEW INVESTIGATIVE APPROACHES ABOUND
10.2 Gene Therapy in Oncology- Market Drivers
10.2.1 GROWING DEMAND FOR GENE THERAPY OVER CONVENTIONAL THERAPIES
10.2.2 ROBUST GOVERNMENT INITIATIVES AND INCREASE IN GOVERNMENT SUPPORT FOR RESEARCH IN GENE THERAPY
10.2.3 EXTENSIVE RESEARCH AND DEVELOPMENT STRATEGIES CARRIED OUT BY BIOPHARMACEUTICAL COMPANIES
10.3 Gene Therapy in Oncology - Market Challenges
10.3.1 HIGH COST OF CANCER GENE THERAPIES AND HIGH VOLUME OF CASES ARE MAJOR CONCERNS FOR PAYERS
10.3.2 SAFETY CONCERNS PERSIST, INCLUDING OFF-TARGET EFFECTS AND ADVERSE IMMUNE REACTIONS TO BACTERIAL CAS9

11.1 Gene Therapy in Oncology Competitive Landscape
11.2 Gene Therapy in Oncology Vendor Snapshot
11.2.1 COMPANY SNAPSHOT: AMGEN INC.
11.2.2 COMPANY SNAPSHOT: BRISTOL-MYERS SQUIBB CO (BMS)
11.2.3 COMPANY SNAPSHOT: GILEAD (KITE PHARMA, INC.)
11.2.4 FKD
11.2.5 GERON
11.2.6 IDERA
11.2.7 ISTARI
11.2.8 VBLS

12.1 Abbreviations
12.2 Methodology
12.3 Key Themes Impacting the Pharmaceutical Industry
12.4 About the Publisher

• Contact the Publisher

Table 1 Key Trends Overview
Table 2 Research scope and segmentation
Table 3 Gene Therapy Classification
Table 4 Global Gene Therapy in Oncology Market
Table 5 Gene Therapy in Oncology by Therapy type, 2020-2027 ($Mn)
Table 6 Gene Therapy in Oncology by End-user, 2020-2027 ($Mn)
Table 7 Gene Therapy in Oncology by Region, 2020-2027 ($Mn)
Table 8 North America Gene Therapy in Oncology by Country, 2020-2027 ($Mn)
Table 9 Europe Gene Therapy in Oncology by Country, 2020-2027 ($Mn)
Table 10 Asia-Pacific Gene Therapy in Oncology by Country, 2020-2027 ($Mn)
Table 11 Gene Therapy in Oncology by Products, 2020-2027 ($Mn)

Figure 1 Market Snapshot
Figure 2 Key Segment Performance Snapshot
Figure 3 History of Gene Therapy Development in Cancer in the 8MM
Figure 4 Industry value chain Analysis
Figure 5 Global Gene Therapy in Oncology PORTER’s Five Force Analysis
Figure 6 Global Gene Therapy in Oncology Market - Revenue Forecast, 2020-2027 (US$ Million)
Figure 7 Gene Therapy in Oncology by Products- Market Overview
Figure 8 Gene Therapy in Oncology by Products Share - 2021 & 2027 (%)
Figure 9 Oncolytic Virotherapy Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 10 Gene Transfer Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 11 Gene Induced Immunotherapy Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 12 Gene Therapy in Oncology by Platform- Market Overview
Figure 13 Gene Therapy in Oncology by End-user - 2021 & 2027 (%)
Figure 14 Hospitals Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 15 Diagnostic Centers Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 16 Research Institutes Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 17 Gene Therapy in Oncology by Region- Market Overview
Figure 18 Gene Therapy in Oncology by Region Share - 2021 & 2027 (%)
Figure 19 North America Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 20 Europe Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 21 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)
Figure 22 ROW Market Revenue Opportunity Forecast, 2020-2027 (US$ Million)